Mediterranean Diet Plus Exercise Lowers Alzhei... (onfer benefit isn't known. It could be ...)

Mediterranean Diet Plus Exercise Lowers Alzheimer's Risk

Date:8/11/2009

onfer benefit isn't known. "It could be there are individual elements of the diet that are important," Scarmeas said. "But it could be the interaction."

In another study published earlier this year, Scarmeas found that those who adhere to a Mediterranean diet had a lower risk of developing cognitive impairment, and a lower risk of developing Alzheimer's disease if they already had cognitive impairment.

In a second study in the same journal, researchers (including Scarmeas) looked at 1,410 French adults and found adherence to a Mediterranean diet was linked to slower decline on one cognitive test but not others. They didn't find high adherence to the heart-healthy diet linked with the risk for dementia.

In an editorial, the Mayo Clinic's Dr. David Knopman writes that a healthy diet may help prevent Alzheimer's but does not seem to occur in isolation.

"For such a benign intervention as diet and exercise, 60 percent [reduction in Alzheimer's] is substantial," said Dr. Greg Cole, associate director of the Mary S. Easton Center for Alzheimer's Disease Research at the University of California Los Angeles David Geffen School of Medicine.

Already, about 5.3 million Americans have Alzheimer's disease, according to the Alzheimer's Association, and up to 16 million may have it by 2050.

"So, the 60 percent reduction from diet and exercise can have a huge impact because we are talking about so many millions of people," Cole said.

The findings are in line with what the Alzheimer's Association already recommends in its "Maintain Your Brain" program, said William H. Thies, vice president for medical and scientific relations for the organization.

"One of the things that is important [to note] is, they are looking at normal people," he said, not those who already have the disease. "You aren't going to cure Alzheimer's disease by eating lots of olives."

More information

To learn
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Mediterranean Diet Aids the Aging Brain: Study
2. Dr. Will Clower To Lead Mediterranean Immersion
3. EAU 2nd Eastern Mediterranean Meeting expected to highlight cystectomy
4. Mediterranean-Style Diet Best for Blood Sugar Control
5. Mediterranean Diet Enriched With Nuts Cuts Heart Risks
6. Mediterranean Diet May Ward Off Type 2 Diabetes
7. Scientists obtain anticancer medicines from the elecampe, a wild plant growing in the Mediterranean
8. Healthful Mediterranean Dining Never Tasted So Good
9. Mediterranean Diet for Mom Fends Off Asthma, Allergies in Kids
10. Medtronic Mediterranean Launches Worlds First Arabic-Language Integrated Insulin Therapy for Improved Diabetes Management
11. Mediterranean Diet May Boost Alzheimers Survival

Post Your Comments:

Related Image:

Mediterranean Diet Plus Exercise Lowers Alzheimer's Risk

(Date:12/14/2009)... Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and Related ... Nearly all unmarried young adults ages 18-29 believe pregnancy ... and 86% of women) and say that it is ... (86% of men and 88% of women), according to ... Teen and Unplanned Pregnancy. Even so: ,, ...

(Date:12/14/2009)... oxygen, drugs, and more… , ... ... in collaboration with scientists at University of Michigan, have developed ... of natural red blood cells, including softness, flexibility, and the ... primary function of natural red blood cells is to carry ...

(Date:12/14/2009)... ARBOR, Mich., Dec. 14 Pepsi ... the Commonwealth of Kentucky are among the major ... this fall to help their employees make better ... solution gives employees a personalized summary of their ... of that care. With this personalized information, employees ...

(Date:12/14/2009)... -- Americold Realty Trust ("Americold") announced today that it ... the U.S. Securities and Exchange Commission (the "SEC") relating ... shares. The number of shares to be offered and ... been determined. The common shares to be sold in ... ,, The joint book-running managers of the offering ...

(Date:12/14/2009)... BRAINTREE, Mass., Dec. 14 Haemonetics Corporation ... it has filed a new legal action to ... Fenwal,s just released red cell collection kits, using ... its separation chamber to circumvent Haemonetics, patent and ... continued sale of infringing products after December 1, ...

Breaking Medicine News(10 mins):Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2 Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3 Health News:Synthetic Red Blood Cells Developed 2 Health News:Synthetic Red Blood Cells Developed 3 Health News:Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process 2 Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2 Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 2 Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 3

[1] Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference [0] Synthetic Red Blood Cells Developed [0] Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process [0] Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering [0] Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement

... SAN DIEGO, Nov. 24 Volcano Corporation (Nasdaq: VOLC ... for the diagnosis and treatment of coronary and peripheral artery disease, ... Piper Jaffray Health Care Conference on Tuesday, December 2. , ... and chief executive officer, will begin at 1:30 p.m., Eastern Standard ...

... Calif., Nov. 24 Thoratec Corporation,(Nasdaq: THOR ... to save, support and restore falling hearts, said today ... Jaffray Heath Care Conference on,Wednesday, December 3. , ... provide an,update on the company, beginning at 1 p.m., ...

... Networks, Inc.(TM), the,company delivering new technology in enterprise ... Networks executive Amit Chawla as its new President,and ... Agito Networks, flagship product is the ... IP telephony, and,location information, improving the accessibility and ...

... Leading Specialty Pharmaceutical Company with Greater Commercialization Capabilities, Expanded Portfolio of ... , King Extends Tender Offer Through December 19, 2008 ... BRIDGEWATER, N.J., Nov. 24 King Pharmaceuticals, Inc. (NYSE: ... announced that the two companies have signed a definitive merger agreement ...

... with Broad Potential to Treat Life-Threatening Viral Infections-- , ... and Equivalent Antibodies Cured Lethal Viral Infections in Preclinical Models-- ... is a ,Druggable, Target Common to a Number of Serious ... Calif., Nov. 24 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) ...

... summarized- , , ... Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian ... Cell Wall-DNA Complex (MCC) - trademarked Urocidin - ... 2008 Societe Internationale d,Urologie (SIU) Congress in Santiago, ...

Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast Thoratec Presentation at Piper Jaffary Conference to be Webcast Agito Networks Names New CEO, Broadens Depth of Experience of Enterprise Mobility Leader King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile

(Date:12/15/2009)... Genomic Health, Inc. (Nasdaq: GHDX ) ... Onco type DX® breast cancer test, a multi-gene ... likelihood of chemotherapy benefit and recurrence risk for patients ... the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, ... TX. ,, "The breadth of data presented at last ...

(Date:12/15/2009)... Arlington Medical Resources (AMR) and Decision ... (MRSA) is the most concerning pathogen to surveyed ... treatment of skin and skin structure infections. A ... factors that influences European physician drug selection for ... factors that drive prescribing include an agent,s skin ...

(Date:12/15/2009)... INDIANAPOLIS, and CAMBRIDGE, Mass., Dec. 15 ... ), Eli Lilly and Company (NYSE: ... ) today announced positive results from a head-to-head ... therapy, to BYETTA® (exenatide) injection taken twice daily, ... weeks of treatment, patients taking exenatide once weekly ...

Breaking Medicine Technology:Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 2 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 3 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 4 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 5 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 6 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 7 Study Forecasts More Young Doctors in Future 59852 1 Study Forecasts More Young Doctors in Future 59852 2 Experimental treatments restore partial vision to blind people 10444 1 Experimental treatments restore partial vision to blind people 10444 2 Minnesota Dentists Warn Halloween Shoppers 3A Sour Candies May Trick Not Treat Teeth 59846 1 Minnesota Dentists Warn Halloween Shoppers 3A Sour Candies May Trick Not Treat Teeth 59846 2

[0] Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations [0] A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections [0] Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study

... Drugs on the Market and, in Clinical Development with Each ... Anticancer Effects, and Expand the Markets for ... ... Identification of novel,cancer-related targets and pathways is redefining our understanding of ...

... Mich., Feb. 19 Compendia Bioscience, Inc.,today announced ... renewed,and expanding commitment from all major customers and ... to its customer roster. The new,customers and existing ... revenue increase, with similar growth forecasted for 2008., ...

Other Medicine Technology:Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 2 Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 3 Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics 4 On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 2 On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments 3

Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments

For the quantitative determination of uric acid in serum....

... new level of immunodiagnostic productivity. Optimal flexibility. ... laboratory automation system. No-pause loading of all ... only immunoassay system with this capability. No ... without any additional setup. Continuous sample loading. ...

... Engineered for continuous, random access operation, the ... medium to large volume laboratories that want ... offers the simplicity, flexibility and Stat capabilities ... can be adapted to the changing needs ...

The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...

Medicine Products:

Uric Acid Reagent Set Advia Centaur Elecsys 2010 Disk System Dimension RxL Max w/o HM 50/60 HZ

Mediterranean Diet Plus Exercise Lowers Alzhei...(onfer benefit isn't known. It could be ...),Health